Cardiac Allograft Vasculopathy
📧 Sign up to get email alerts when something new happens for Cardiac Allograft Vasculopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation [Phase 2]
Phase 2 trial investigating rituximab therapy to prevent cardiac allograft vasculopathy in heart transplant recipients; the study was termin…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating mesenchymal stem cell therapy for coronary graft disease in heart transplant patients is currently suspended.
-
CLINICAL_TRIALS withdrawal · 2017-01-25Clinical Trial Update: Noninvasive Predictors of Transplant Vasculopathy
The clinical trial 'Noninvasive Predictors of Transplant Vasculopathy' (NCT01424917) investigating cardiac allograft vasculopathy has been w…
-
CLINICAL_TRIALS withdrawal · 2017-01-24Clinical Trial Update: Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients [NA]
A clinical trial evaluating strategies to prevent cardiac allograft vasculopathy in heart transplant recipients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-15Clinical Trial Update: Noninvasive Evaluation of Cardiac Allograft Vasculopathy
A clinical trial evaluating noninvasive evaluation of cardiac allograft vasculopathy was withdrawn by the sponsor, University of Minnesota.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation [Phase 2]
A Phase 2 trial evaluating pioglitazone to prevent cardiac allograft vasculopathy after heart transplantation has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy [NA]
A completed clinical trial evaluating the effect of Angiotensin Converting Enzyme (ACE) inhibition on Cardiac Allograft Vasculopathy, with r…
-
CLINICAL_TRIALS withdrawal · 2016-06-20Clinical Trial Update: Coronary Artery Study in Pediatric Heart Transplantation
A pediatric heart transplant trial focusing on coronary artery disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-19Clinical Trial Update: Severe CAV MRI in Heart Transplant Recipient
A clinical trial evaluating MRI for severe cardiac allograft vasculopathy in heart transplant recipients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography [Phase 4]
This is a Phase 4 clinical trial update from the University of Zurich. The study uses intracoronary optical coherence tomography to analyze …
-
CLINICAL_TRIALS research · 2014-08-29Clinical Trial Update: Identification of Non Invasive Biomarkers of Immune Endothelial Injury and Repair Associated With Cardiac Allograft Vasculopathy [NA]
This clinical trial update reports efforts to identify noninvasive biomarkers of immune endothelial injury and repair in cardiac allograft v…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography
This completed clinical trial evaluated the use of optical coherence tomography to assess cardiac allograft vasculopathy.
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy [Phase 3]
A completed Phase 3 trial evaluating the safety and efficacy of everolimus in combination with cyclosporine (Neoral) in adult heart transpla…
-
CLINICAL_TRIALS research · 2009-08-27Clinical Trial Update: Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy [Phase 3]
Phase 3 clinical trial evaluating prevention of cardiac allograft vasculopathy in heart transplant recipients using everolimus in combinatio…
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant [Phase 4]
This Phase 4 clinical trial is evaluating everolimus for progression of graft vascular disease in heart transplant recipients.